Anzeige
Mehr »
Montag, 22.12.2025 - Börsentäglich über 12.000 News
Breaking News: "Königs-Exosomen" senken Entzündungslevel um 90%…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41H07 | ISIN: US8549362007 | Ticker-Symbol: W3T0
NASDAQ
22.12.25 | 21:59
3,290 US-Dollar
+1,23 % +0,040
Branche
Elektrotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
STARDUST POWER INC Chart 1 Jahr
5-Tage-Chart
STARDUST POWER INC 5-Tage-Chart

Aktueller Chart STARDUST POWER Aktie

Chart vergleichen mit:

Firmenname, WKN, ISIN oder Aktien-Kürzel

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%
Chart-Typ:
Zeitraum:
 
STARDUST POWER INC-Investoren interessieren sich auch für diese Wertpapiere
Oversonic Robotics To Supply Humanoids To STMicroelectronics' Semiconductor PlantsGENEVA (dpa-AFX) - Oversonic Robotics announced the signing of an agreement with STMicroelectronics (STM) for the introduction of custom RoBee cognitive humanoid robots into the production and...
► Artikel lesen
Oversonic Robotics signs humanoid robots supply agreement with STMicroelectronicsOversonic to supply custom humanoids to ST's global network of semiconductor plantsCollaborative demo during CES MILAN, Dec. 22, 2025 /PRNewswire/ -- Oversonic Robotics, an Italian company...
► Artikel lesen
STMicroelectronics N.V.: Resolutions approved at the Extraordinary General Meeting of ShareholdersResolutions approved at the Extraordinary General Meeting of Shareholders Amsterdam, December 18, 2025 - STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the...
► Artikel lesen
VivoSim Labs, Inc.: VivoSim Labs Appoints Tony Lialin as Chief Commercial OfficerSAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "VivoSim Labs"), a pharmaceutical and biotechnology services company that is focused on providing testing...
► Artikel lesen
INOVIO Pharmaceuticals, Inc.: INOVIO Reports Third Quarter 2025 Financial Results and Recent Business HighlightsCompleted rolling Biologics License Application (BLA) submission seeking accelerated approval for lead candidate INO-3107; requested priority review Expect...
► Artikel lesen
INOVIO Pharmaceuticals, Inc.: INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in AdultsRecurrent respiratory papillomatosis (RRP) is a rare HPV-related disease of the respiratory tract with significant unmet need INO-3107 previously received...
► Artikel lesen
INOVIO Pharmaceuticals, Inc.: INOVIO Reports Inducement Grant Under Inducement PlanPLYMOUTH MEETING, Pa., Oct. 31, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help...
► Artikel lesen